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Summary
  Introduction:  The subject of the study compare the influences of YC-1 guanylyl cyclase activator with ODQ 
guanylyl cyclase inhibitor on the tracheal smooth muscle contraction induced by carbachol. The 
study specified the influence of increasing concentrations of soluble guanylyl cyclase activators 
YC-1 and 8Br cGMP on the reaction of tracheal smooth muscle contraction released by carba-
chol. The author also examined the effect of increasing concentrations of soluble guanylyl cyc-
lase inhibitor ODQ on the concentration-effect curves for carbachol.
  Material/Methods:  Testing was conducted on an isolated trachea of both sexes of Wistar rats with weight ranging 
between 350 g and 450 g. Tracheas were prepared in accordance with the Akcasu (1959) method 
in Szadujkis-Szadurski (1996) modification. Concentration-effect curves were determined with 
the use of cumulated concentration method, in accordance with the van Rossum method (1963) 
in Kenakin (2006) modification.
  Results:  According to conducted testing, activation of soluble guanylyl cyclase with the use of YC-1 and 
8Br cGMP caused reduced reaction of the tracheal smooth muscle with carbachol on average to 
80%. Comparing concentration-effect curves for carbachol before and after the use of 8Br cGMP, 
similar results were obtained for those released by YC-1.
    On the other hand, increasing concentrations of guanylyl cyclase inhibitor – ODQ cause shift of 
curves to the left, decrease of EC50 value and an increase of maximum reaction to carbachol.
  Conclusions:  Carbachol, depending on concentration, causes tracheal smooth muscle contraction. According 
to testing, we can confirm that activation of guanylyl cyclase leads to reduction of the reaction of 
tracheal smooth muscle to carbachol on average up to 80%
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Streszczenie
  Wstęp:  Przedmiotem pracy jest określenie działania aktywatorów cyklazy guanylanowej na reakcję skur-
czu mięśniówki gładkiej tchawicy. W pracy oznaczano wpływ wzrastających stężeń aktywato-
ra cyklazy guanylanowej YC-1 oraz 8Br cGMP na reakcję skurczu mięśniówki gładkiej wyzwa-
laną karbacholem. Badano także wpływ wzrastających stężeń inhibitora cyklazy guanylanowej 
ODQ na krzywe stężenie–efekt dla karbacholu.
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       -               -               -               -               -       IntroductIon
Nitric oxide (NO) induces airway smooth muscle cell (SMC) 
relaxation, but the underlying mechanism is not well under-
stood. In the airways and lungs, nitric oxide (NO) is pro-
duced by epithelial ciliated cells, type II alveolar cells, and 
neural fibers that innervate the airway smooth muscle cells 
(SMCs) [19]. The NO released by these cells decreases air-
way resistance and that NO, released by neural fibers, is a 
major nonadrenergic, noncholinergic neurotransmitter re-
sponsible for airway SMC relaxation [5]. Furthermore, the 
signaling cascade by which NO induces smooth muscle re-
laxation has been mainly studied on vascular smooth mu-
scle cells. In these blood vessels, NO is synthesized in the 
endothelial cells and diffuses to the adjacent SMCs, where 
it activates soluble guanylate cyclase (sGC) to synthesize 
cGMP. From these studies it is well known that cGMP acts 
as a second messenger to activate cGMP-dependent PKG 
and/or other effector proteins, including ion channels, ion 
pumps, and phosphodiesterases (PDEs) [6, 14]. Thus cGMP 
were involved in the phosphorylation of one or more target 
molecules by PKG and/or a direct activation/inhibition of 
ion channels by cGMP are believed to lead to smooth mu-
scle relaxation. For these reason, we investigated the ef-
fects of ODQ an inhibitor and YC-1 an activator of soluble 
guanylyl cyclase (CGs) on airway SMC contraction indu-
ced by carbachol and we extended this study to investiga-
te and compare the effects of ODQ and YC-1 with the ef-
fect of 8Br cGMP on airway relaxation.
The subject of the study is determination of the activi-
ty of the nitric oxide (NO)-independent activators of so-
luble guanylyl cyclase activators YC-1 and selctive inhi-
bitors ODQ in the modulation of the reaction of tracheal 
smooth muscle contraction. The study specified the influ-
ence of increasing concentrations of guanylyl cyclase ac-
tivators YC-1 and 8Br cGMP on the reaction of tracheal 
smooth muscle contraction released by carbachol. The au-
thor also examined the effect of increasing concentrations 
of guanylyl cyclase inhibitor ODQ on the concentration-
-responses curves for carbachol.
Natural activators of guanylyl cyclase include nitric oxide 
and carbon monoxide. Both nitric oxide (NO) and carbon 
monoxide (CO) activate soluble guanylyl cyclase, binding 
with the heme group of this enzyme [10,22]. NO is produ-
ced through the conversion of l-arginine to citrulline by the 
enzyme NO synthase (NOS). In the lung, endothelial NOS 
(eNOS) is found in both vascular endothelium and airway 
epithelium [15]. CO shows significantly lower activity in 
this process than NO [24]. NO and cGMP have an impor-
tant role in regulating pulmonary vascular tone and deve-
lopment. NO produced by nitric oxide synthase (NOS) in 
pulmonary endothelial cells diffuses into subjacent smo-
oth muscle cells (SMC) where it stimulates soluble gu-
anylyl cyclase (sGC) to increase cGMP production [3,18].
Although cGMP interacts with several proteins in SMC, 
cGMP regulates pulmonary vascular tone primarily by sti-
mulating cGMP-dependent protein kinase I (PKGI). Cyclic 
GMP-activated PKGI phosphorylates several cytosolic pro-
tein targets that regulate intracellular Ca2+ levels, the cal-
cium sensitivity of the contraction apparatus, and thin fi-
lament proteins and thereby cause vasodilatation [3,18].
Smooth muscle contraction may be regulated by Ca2+ thro-
ugh two pathways initiated by depolarization and agonist, 
 Materiał/Metody:  Badania przeprowadzono na izolowanej tchawicy szczurów szczepu Wistar obu płci o masie 
350–450 g. Tchawice preparowano zgodnie z metodą (Akcasu) (1959) w modyfikacji Szadujkis-
Szadurski (1996). Krzywe stężenie–efekt wyznaczano metodą stężeń kumulowanych, zgodnie 
z metodą van Rossuma (1963) w modyfikacji Kenakin (2006).
  Wyniki:  Z przeprowadzonych badań wynika, że aktywacja cyklazy guanylanowej za pomocą YC-1 i 8Br 
cGMP powoduje obniżenie reakcji mięśniówki gładkiej tchawicy na karbacholu średnio do 80%. 
Z porównania krzywych stężenie–efekt dla karbacholu przed i po zastosowaniu 8Br cGMP uzy-
skano podobne wyniki do wyzwalanych przez YC-1.
    Natomiast wzrastające stężenia inhibitora cyklazy guanylanowej – ODQ powodują przesunięcie 
krzywych w lewo, obniżenie wartości EC50 i podwyższenie maksymalnej reakcji na karbacholu. 
Można więc stwierdzić, że działanie ODQ jest odwrotne do działania 8Br cGMP i YC-1.
  Wnioski:  Karbachol w sposób zależny od stężenia powoduje skurcz mięśniówki gładkiej tchawicy. Z prze-
prowadzonych badań wynika, że aktywacja cyklazy guanylanowej powoduje obniżenie reakcji 
mięśniówki gładkiej tchawicy na karbachol średnio do 80%.
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       -               -               -               -               -       respectively. Depolarization of the cell membrane activates 
voltage-gated Ca2+ channels resulting in Ca2+ influx, where-
as agonist stimulation generally activates G protein-coupled 
receptors (GPCRs) leading to inositol 1,4,5-trisphosphate 
formation and Ca2+ release from the sarcoplasmic reticu-
lum. The increase in cytosolic Ca2+ leads to smooth musc-
le contraction through myosin light chain kinase (MLCK) 
activation by Ca2+/calmodulin and myosin regulatory light 
chain (RLC) phosphorylation. Additionally, activation of 
GPCRs leads to inactivation of MLCP by agonist-indu-
ced protein kinase C (PKC) and RhoA/ROCK activation. 
These inhibitory mechanisms thus enhance RLC phospho-
rylation and force development [23].
Tests, conducted in this study, indicate that in addition to 
the modulating component related to guanylyl cyclase in 
reaction of contraction to carbachol, there is a component 
independent of this nucleotide participating in this process.
MaterIal and Methods
Testing was conducted on an isolated trachea of both se-
xes of Wistar rats with weight ranging between 350 g and 
450 g. Tracheas were prepared in accordance with the 
Akcasu method (1959) [1] in Szadujkis-Szadurski mo-
dification (1996) [20]. A chain of combined segments of 
the trachea with 4 cm in length was placed in a dish for 
isolated organs. This dish was filled with Krebs fluid and 
oxidized, after previous addition of 5% CO2. Reaction of 
the trachea was registered with the use of isotonic trans-
ducer Biograf F-60 and recorded by polyphysiograph 
Narco Bio-System Narcotrace 40 (USA). Tested compo-
unds were added directly to the dish, in which the tra-
chea was placed.
Concentration-effect curves for tested agonists were de-
termined with the use of traditional van Rossum’s phar-
macometric method. EC50 values were determined using 
the linear regression method for the range between 20% 
and 80% of reaction. The value of dissociation constant 
of agonist-receptor complex was determined with the use 
of the Furchgott and Bursztyn method in Kenakin T mo-
dification (1997) [13].
The following reagents were used in testing: Carbachol, 
8 Br cGMP (Beringher), 3-(5’-hydroxymethyl-2’-furyl)-
-1-benzylindazole (YC-1), (Sigma), 1,2,4-oxodiazolo-[4,3-
-a]quinoxalin-1-one (ODQ) (Sigma).
The experiments were carried out using of Krebs’ fluid (nor-
mal) – PSS – composition: NaCl (71.8 mM/L), KCl (4.7 
mM/L), CaCl2 (1.7 mM/L), NaHCO3 (28.4 mM/L), MgSO4 
(2.4 mM/L), KH2PO4 (1.2 mM/L), glucose (11.1 mM/L) 
with the addition of EGTA (30 µM/L).
results
Carbachol in the range of concentrations between 10–10 and 
10–6 M/l leads to tracheal smooth muscle contraction, de-
pendent on concentration. The average EC50 value was de-
termined from concentration-effect curves for carbachol, 
amounting to 2.76 (±0.11)×10–8 M/l for n=9.
Results are shown on Fig. 1.
Increasing concentration 8Br cGMP (10–100 µM/l) cau-
ses shifting of the concentration –response curve to the 
right with the decrease of maximum reaction to carba-
chol. Under the influence of this activity, EC50 for carba-
chol increases along with an increase of concentration 
8Br cGMP. Average values EC50 for carbachol are pre-
sented in Table 1.
Increasing concentration YC-1(1–10 µM/l) causes shift 
of the curve into the right, with the decrease of maxi-
mum reaction to carbachol. Under the influence of the 
activity, EC50 for carbachol increases along with concen-
tration YC-1. Average values EC50 for carbachol are pre-
sented in Table 2.
Fig. 1.  Concentration-effect curves for carbachol 2.76 (±0.11)×10–8. Points 
marked on the curve present average values and SE ± for n=9
Fig. 2.  Effect of increasing concentrations (from 10–8 to 10–7 [M/l]) 8Br 
cGMP on the concentration-effect curve for carbachol. Points 
marked on curves present average values and SE ± for n =9
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       -               -               -               -               -       Increasing concentration ODQ (10–100 µM/l) causes shift 
of the curve into the left with simultaneous increase of ma-
ximum reaction to carbachol. Average value Em for carba-
chol under the influence of ODQ increases by 31(±6.6)%. 
Under the presence of ODQ, the average value EC50 for 
carbachol decreases from 2.76 (±0.11)×10–8 M/l to 4.11 
(±0.14)×10–9 M/l. Average results obtained in this series 
of experiments are summarized in Table 3.
dIscussIon
In the airways and lungs, nitric oxide (NO) is produced by 
epithelial ciliated cells, type II alveolar cells, and neural 
fibers that innervate the airway smooth muscle cells [19]. 
Earlier research on modulating activity of cyclical nucle-
otides on the reaction of tracheal smooth muscle contrac-
tion indicated that cAMP and analogy of this nucleotide 
cause both relaxation and reduce the reaction of tracheal 
smooth muscle to contracting agents. Similar activity mo-
dulating smooth muscle contraction induces NO which ac-
tivate of the soluble guanylyl cyclase and 8Br cGMP per-
meable analog of cGMP [4,8,11,12].
According to presented research, 8 Br cGMP – induced 
concentration depending reduces the reaction of tracheal 
smooth muscle contraction induced by carbachol. Under 
the influence of this cyclic nucleotide, concentration-effect 
curves for carbachol shift to the right with simultaneous 
reduction of the effect of maximum reaction. From the 
analysis of concentration-effect curves for carbachol, de-
termined before and after the use of 8Br cGMP, we can 
deduce that this nucleotide behaves like allosteric antago-
nist. Further testing established that YC-1 selective acti-
vator of soluble guanylyl cyclase modulates in a similar 
way reaction of the trachea to carbachol. Antagonistic ac-
tion of YC-1 in relation to carbachol in accordance with 
the principles of the receptor theory also meets the condi-
tions of allosteric antagonist [2,7,13,21].
Additional testing analyzed the influence of soluble gu-
anylyl cyclase inhibitor – ODQ on the reaction of trache-
al smooth muscle contraction induced by carbachol. The 
Drug n EC50 (± SE)
Carbachol 9 2.76 (± 0.11)×10–8
Carbachol + 8Br cGMP 10 µM 9 4.92 (± 0.07)×10–8
Carbachol+ 8Br cGMP 30 µM 9 1.67 (± 0.05)×10–7
Carbachol+ 8Br cGMP 100 µM 9 4.31 (± 0.04)×10–7
Table 1.   Influence of carbachol on the reaction of tracheal smooth 
muscle contraction before and after the use of increasing 
concentrations 8Br cGMP
Drug n EC50 (±SE)
Carbachol 9 2.76 (±0.11)×10–8
Carbachol + YC-1 1 µM 9 8.3 (±0.04)×10–8
Carbachol+ YC-1 3 µM 9 1.7 (±0.07)×10–7
Carbachol+ YC-1 10 µM 9 6.71 (±0.06)×10–7
Table 2.   Influence of carbachol on the reaction of tracheal smooth 
muscle contraction before and after the use of increasing 
concentrations YC-1
Drug n EC50 (±SE)
Carbachol 9 2.76 (±0.11)×10–8
Carbachol + ODQ 10 µM 9 1.21 (±0.23)×10–8
Carbachol+ ODQ 30 µM 9 7.27 (±0.16)×10–9
Carbachol+ ODQ 100 µM 9 4.11 (±0.14)×10–9
Table 3.   Influence of carbachol on the reaction of tracheal smooth 
muscle contraction before and after the use of increasing 
concentrations ODQ
Fig. 3.  Effect of increasing concentrations (from 10–8 to 10–7 [M/l]) YC-1 
on the concentration-effect curve for carbachol. Points marked on 
curves present average values and SE ± for n =9
Fig. 4.  Effect of increasing concentrations (from 10–9 to 10–8 [M/l]) ODQ 
on the concentration-effect curve for carbachol. Points marked on 
curves present average values and SE ± for n =9
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bachol shows that the increasing concentrations of ODQ 
have a statistically significant effect on the shift of curves 
to the left with simultaneous reduction of EC50 values and 
increase of maximum reaction to carbachol by 31(±6.6)% 
for n=9. The activity of ODQ is opposite to the activity of 
8Br cGMP and YC-1 [9,11].
Increase of cGMP results in decrease of the tracheal smo-
oth muscle contraction.
These results suggest a possibility of the use of activators 
of guanylyl cyclase in treatment of spastic bronchitis [8,16].
conclusIons
•	 	 Carbachol,	depending	on	concentration,	causes	trache-
al smooth muscle contraction.
•	 	 According	to	testing,	we	can	confirm	that	activation	of	
guanylate cyclase leads to reduction of the reaction of 
tracheal smooth muscle to carbachol on average up to 
80%.
•	 	 Comparing	concentration-effect	curves	for	carbachol,	
before and after the use of 8Br cGMP, similar results 
were obtained for those released by YC-1.
•	 	 It	indicates	that	regardless	of	modulating	component	re-
lated to guanylate cyclase in reaction of contraction to 
carbachol, a component independent of this nucleotide 
participates in the process.
•	 	 Confirmation	of	participation	of	CG	and	cGMP	in	re-
gulation of tracheal smooth muscle contraction released 
by carbachol was obtained by the use of inhibitor ODQ.
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